81 related articles for article (PubMed ID: 15459498)
21. Identification of immunohistochemical prognostic markers for survival after resection of pulmonary metastases from colorectal carcinoma.
Pfannschmidt J; Bade S; Hoheisel J; Muley T; Dienemann H; Herpel E
Thorac Cardiovasc Surg; 2009 Oct; 57(7):403-8. PubMed ID: 19795327
[TBL] [Abstract][Full Text] [Related]
22. Tumor invasion of lymph node capsules in patients with Dukes C colorectal adenocarcinoma.
Yano H; Saito Y; Kirihara Y; Takashima J
Dis Colon Rectum; 2006 Dec; 49(12):1867-77. PubMed ID: 17080279
[TBL] [Abstract][Full Text] [Related]
23. How many lymph nodes should be examined in Dukes' B colorectal cancer? Determination on the basis of cumulative survival rate.
Yoshimatsu K; Ishibashi K; Umehara A; Yokomizo H; Yoshida K; Fujimoto T; Watanabe K; Ogawa K
Hepatogastroenterology; 2005; 52(66):1703-6. PubMed ID: 16334761
[TBL] [Abstract][Full Text] [Related]
24. Clinicopathological relevance of HER2/neu and a related gene-protein cubic regression correlation in colorectal adenocarcinomas in Taiwan.
Li JW; Chuang TC; Yang AH; Hsu CK; Kao MC
Int J Oncol; 2005 Apr; 26(4):933-43. PubMed ID: 15753987
[TBL] [Abstract][Full Text] [Related]
25. Legumain expression in relation to clinicopathologic and biological variables in colorectal cancer.
Murthy RV; Arbman G; Gao J; Roodman GD; Sun XF
Clin Cancer Res; 2005 Mar; 11(6):2293-9. PubMed ID: 15788679
[TBL] [Abstract][Full Text] [Related]
26. The prediction of lymph node metastases in colorectal cancer by expression of the nucleoside diphosphate kinase/nm23-H1 and histopathological variables.
Tannapfel A; Katalinic A; Köckerling F; Wittekind C
Am J Gastroenterol; 1997 Jul; 92(7):1182-6. PubMed ID: 9219795
[TBL] [Abstract][Full Text] [Related]
27. Stromelysin-3 mRNA expression and malignancy: comparison with clinicopathological features and type IV collagenase mRNA expression in breast tumors.
Kawami H; Yoshida K; Ohsaki A; Kuroi K; Nishiyama M; Toge T
Anticancer Res; 1993; 13(6A):2319-23. PubMed ID: 8297152
[TBL] [Abstract][Full Text] [Related]
28. Expression of cell cycle control proteins in primary colorectal tumors does not always predict expression in lymph node metastases.
McKay JA; Douglas JJ; Ross VG; Curran S; Ahmed FY; Loane JF; Murray GI; McLeod HL
Clin Cancer Res; 2000 Mar; 6(3):1113-8. PubMed ID: 10741741
[TBL] [Abstract][Full Text] [Related]
29. Expression of annexin a5 is associated with higher tumor stage and poor prognosis in colorectal adenocarcinomas.
Xue G; Hao LQ; Ding FX; Mei Q; Huang JJ; Fu CG; Yan HL; Sun SH
J Clin Gastroenterol; 2009 Oct; 43(9):831-7. PubMed ID: 19461527
[TBL] [Abstract][Full Text] [Related]
30. 5-Lipoxygenase is coexpressed with Cox-2 in sporadic colorectal cancer: a correlation with advanced stage.
Barresi V; Grosso M; Vitarelli E; Tuccari G; Barresi G
Dis Colon Rectum; 2007 Oct; 50(10):1576-84. PubMed ID: 17762961
[TBL] [Abstract][Full Text] [Related]
31. MMP-9 is differentially expressed in primary human colorectal adenocarcinomas and their metastases.
Illemann M; Bird N; Majeed A; Sehested M; Laerum OD; Lund LR; Danø K; Nielsen BS
Mol Cancer Res; 2006 May; 4(5):293-302. PubMed ID: 16687484
[TBL] [Abstract][Full Text] [Related]
32. [Expression of metallothionein and FasL in colorectal cancer and its clinical significance].
Li SY; Yu B; An P; Zuo FY; Cai HY
Zhonghua Wai Ke Za Zhi; 2005 Sep; 43(17):1118-20. PubMed ID: 16194308
[TBL] [Abstract][Full Text] [Related]
33. Matrix metalloproteinase 2 promotes cell growth and invasion in colorectal cancer.
Dong W; Li H; Zhang Y; Yang H; Guo M; Li L; Liu T
Acta Biochim Biophys Sin (Shanghai); 2011 Nov; 43(11):840-8. PubMed ID: 21968416
[TBL] [Abstract][Full Text] [Related]
34. Overexpression of matrix metalloproteinase 11 in human gastric carcinoma and its clinicopathologic significance.
Zhao ZS; Chu YQ; Ye ZY; Wang YY; Tao HQ
Hum Pathol; 2010 May; 41(5):686-96. PubMed ID: 20060156
[TBL] [Abstract][Full Text] [Related]
35. Epidermal growth factor receptor (EGFR) status in primary colorectal tumors does not correlate with EGFR expression in related metastatic sites: implications for treatment with EGFR-targeted monoclonal antibodies.
Scartozzi M; Bearzi I; Berardi R; Mandolesi A; Fabris G; Cascinu S
J Clin Oncol; 2004 Dec; 22(23):4772-8. PubMed ID: 15570078
[TBL] [Abstract][Full Text] [Related]
36. [Clinical significance of detection on lymphatic microvessel, lymphatic microvessel density and vascular endothelial growth factor-C in patients with colorectal carcinoma].
Fan YZ; Li GM; Huang GP; Li XP
Zhonghua Wei Chang Wai Ke Za Zhi; 2006 Nov; 9(6):477-82. PubMed ID: 17143789
[TBL] [Abstract][Full Text] [Related]
37. Expression of matrix metalloproteinase-1 in human colorectal carcinoma.
Shiozawa J; Ito M; Nakayama T; Nakashima M; Kohno S; Sekine I
Mod Pathol; 2000 Sep; 13(9):925-33. PubMed ID: 11007031
[TBL] [Abstract][Full Text] [Related]
38. Reduced p16 expression correlates with lymphatic invasion in colorectal cancers.
Tada T; Watanabe T; Kazama S; Kanazawa T; Hata K; Komuro Y; Nagawa H
Hepatogastroenterology; 2003; 50(54):1756-60. PubMed ID: 14696398
[TBL] [Abstract][Full Text] [Related]
39. [Expression and clinical significance of IGF-II mRNA and bcl-2 protein in colorectal adenocarcinomas].
Zhang MS; Yuan HY; Xiong B; Deng Q; Tang ZJ; Xia D
Ai Zheng; 2002 Nov; 21(11):1226-30. PubMed ID: 12526221
[TBL] [Abstract][Full Text] [Related]
40. For patients with Dukes' B (TNM Stage II) colorectal carcinoma, examination of six or fewer lymph nodes is related to poor prognosis.
Caplin S; Cerottini JP; Bosman FT; Constanda MT; Givel JC
Cancer; 1998 Aug; 83(4):666-72. PubMed ID: 9708929
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]